Health
Study identifies therapeutic targets for most lethal pancreatic cancer – Drug Target Review
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Posted: 15 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Using preclinical models, researchers have identified two promising therapeutic targets for the most aggressive and lethal form of pancreatic cancer, adenosquamous cancer of the pancreas (ASCP).
The team of researchers led by Mayo Clinic and the Translational Genomics Research Inst…
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General13 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News18 hours agoBrisbane rising on global rankings, but still behind southern capitals